Braxia Scientific Corp (BRAXF)
Braxia Scientific Corp. is a Toronto-based healthcare company focused on medical research and mental health treatment services. Through its clinics, the company provides ketamine-based treatments for patients with depression and related disorders, and it also operates multidisciplinary clinics that treat a range of mental health conditions. Alongside its clinical activities, Braxia Scientific pursues research aimed at developing and commercializing new drugs and delivery methods. Its broader work includes the development and acquisition of ketamine and psilocybin derivatives, as well as other psychedelic-related products, through its intellectual property platform. The company’s common stock trades on OTC Markets.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-BRAX.F
|
Not available
|
Not available
|
Not available
|
Fair
|
0.0%
|
1.007 M
|